Personal Injury News

DePuy ASR Hip Replacement 50% Failure Rate

A joint medical research report released by the British Orthopaedic Association and the British Hip Society stated that DePuy ASR hip implants are failing at a much higher rate that expected. According to the research compiled by a panel of experts on orthopedic devices, the DePuy ASR hip replacement fails at a rate of 21 percent after four years to 49 percent after six years.

DePuy Orthopaedics, a wholly owned subsidiary of corporate giant Johnson & Johnson, issued a global recall on all ASR hip implant devices after the National Joint Registry of the UK reported that 12-13 percent of ASR patients would require a second surgeries within five years. According to Bloomberg News, an estimated 37,000 people in the US received an ASR hip replacement. An estimated 18,500 patients may have to go under the knife for an unwanted, second hip replacement surgery.

Heads are beginning to roll at the orthopedic maker, with David Floyd, the President of DePuy recently submitting his resignation as from the company. A DePuy spokeswoman was quoted as saying that Floyd is stepping down at the end of March to “pursue other interests”.

DePuy hip recall lawsuits are expected to cost Johnson & Johnson billions of dollars. The corporation has already set aside nearly $1 billion to deal with the expected initial surge of personal injury claims. They have chosen Broadspire, an insurance adjustment firm to handle hip implant injury claims. Product liability lawsuits against DePuy are being filed on behalf of hip replacement recall victims across the country. Our experienced hip recall lawyer is available to help, and can answer all your hip implant case questions.

Comments are closed.